Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
ZUG, Switzerland, March 31, 2026 (GLOBE NEWSWIRE) -- PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic...
-
PRIME designation follows recent Breakthrough Therapy designation from the U.S. FDA, underscoring the importance and urgency of addressing optic neuritis, a serious condition that can have negative...
-
Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease Rezurock is now approved in the EU for adults and children aged 12 years and older with chronic GVHD, providing a new...
-
Pelvic Floor Strong exercise claims, Layer Syndrome framework, and Alex Miller's three-step pelvic floor method for women over 40 outlined.
-
2026 report evaluating Hume Health Hume Body Pod accuracy claims, review of 98% DEXA details, 45+ metrics vs. leading bathroom scales.
-
Hume Health Hume Band claims evaluated — Metabolic Momentum, biological age tracking, AI longevity metrics, pricing, and what to verify in 2026.
-
Innovative Food Holdings, Inc. Reports Financial Results for Fourth Quarter and Fiscal Year 2025
-
Brain Savior explains its Brain Honey formula claims, Citicoline and Bacopa Monnieri research, and cognitive support positioning for 2026.
-
EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“SNDL” or the “Company”) announced today that Tyler Robson, President of Cannabis, has left the Company in...
-
REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...